Join
Live feed
·
INSIDERFilingvia Quantisnow
Madrigal Pharmaceuticals Inc. logo

President and CEO Sibold William John converted options into 50,000 shares and sold $1,368,253 worth of shares (2,500 units at $547.30), increasing direct ownership by 29% to 209,329 units (SEC Form 4) to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MDGL (Madrigal Pharmaceuticals Inc.) and more on Quantisnow.